AdhereHealth CEO to Lead the University of Tennessee Health Science Center's Discussions on Medication Adherence and Achieving the Quintuple Aim of Healthcare
Retrieved on:
Thursday, September 7, 2023
NASHVILLE, Tenn., Sept. 7, 2023 /PRNewswire/ -- AdhereHealth, a healthcare technology leader in medication adherence insights and health outcomes, announced today that CEO, Jason Rose, will join the University of Tennessee Health Science Center (UTHSC) College of Pharmacy's (COP) continuing education program to discuss medication adherence and its impact on the quintuple aim of healthcare. The series of live virtual events will take place on September 7, October 5 and November 2, 2023.
Key Points:
- The series of live virtual events will take place on September 7, October 5 and November 2, 2023.
- "Poor medication adherence is tied to approximately half of all treatment failures, more than 125,000 avoidable deaths, and more than half a trillion dollars in wasted spending each year," said Jason Rose, CEO of AdhereHealth.
- To achieve value-based care goals and improve patient experiences, health plans need better tools to address medication adherence at its source."
- To learn more about AdhereHealth solutions and the benefits they deliver for health plans, visit Adherehealth.com.